This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during June 2024 (epidemiological weeks 23-26). The data is dependent on submission of samples by clinicians and therefore may not be...
Since May 2022, more than 97 000 cases of mpox have been reported globally from 117 countries, with 186 deaths (as of 31 May 2024). Between June and September of 2022, five cases of mpox were reported in South Africa, with no fatalities. All of these cases reported...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during May 2024 (epidemiological weeks 18-22). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2024 (epidemiological weeks 14-17). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2024 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and B continued to be detected at low rates during February (≤ 5%). RSV detection rates increased from 4% to 8% during the reporting period but did not reach the threshold for the start of RSV...
Respiratory viruses Human rhino/enteroviruses were the most commonly detected respiratory viruses during January 2024.Similar to December 2023, SARS-CoV-2 detection rates were in the range of 10-12%.Percentage positivity for the other respiratory viruses remained...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2023, with additional data from December 2023. As with the monthly respiratory pathogen reports, the data is dependent on...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 • Influenza A and RSV detection rates remained low during November (≤ 2%). • The highest detection rates for influenza B percentage occurred in week 47 at 8%. • SARS-CoV-2 detection rates in weeks 44 - 47...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and RSV detection rates were below 2% during October. Influenza B cases continued to be detected during October with positivity rates reaching 5% in weeks 42 and 43, but remained below the...